Antagonistic Activity of Polyfermenticin SCD Against Helicobacter pylori KCTC 2948

  • Published : 2004.02.01

Abstract

Bacillus polyfermenticus SCD and polyfermenticin SCD, named tentatively as the bacteriocin produced by B. polyfermenticus SCD, showed antimicrobial activity against Helicobacter pylori KCTC 2948 growth. When crude polyfermenticin SCD was added to the growing H. pylori cells, viable cell numbers were reduced, indicating antimicrobial action. The antimicrobial effect was increased remarkably at higher concentrations of polyfermenticin SCD and longer exposure. Morphological changes were observed in the bacteriocin-treated cells; in the exponential phase, they appeared as shrunken rods, while in the stationary phase, they showed coccoid forms.

References

  1. Graham, D. Y., G. M. Lew, P. D. Klein, D. G. Evans, Z. A. Saeed, and H. M. Malaty. 1992. Effect of treatment of Helicobacter pylori infection on the long term recurrence of gastric or duodenal ulcer - a randomize, controlled study. Ann. Intern. Med. 116: 705-708
  2. Harris, A. 1997. Treatment of Helicobacter pylori. Drugs Today 33: 59-66
  3. Kim, J.-M., J.-E. Shin, M. J. Han, S.-H. Park, and D.-H. Kim. 2003. Inhibitory effect of Ginseng saponins and polysaccharides on infection and vacuolation of Helicobacter pylori. J. Microbiol. Biotechnol. 13: 706-709
  4. Kim, M.-R., S.-K. Yun, W.-J. Lim, B.-S. Hong, and S.-Y. Hwang. 1999. Synergistic inhibition of membrane ATPase and cell growth of Helicobacter pylori by ATPase inhibitors. J. Microbiol. Biotechnol. 9: 414-421
  5. Koo, J.-K., C.-H. Kim, and T.-B. Choe. 1999. Inhibition of growth and adhesion of Helicobacter pylori using egg yolk antibodies. Biotechnol. Bioprocess Eng. 4: 219-223
  6. Lee, K.-H. and H.-D. Paik. 1999. Gastric and bile acid tolerance on commercial probiotic products. Environ. Res. 22: 73-78. https://doi.org/10.1016/0013-9351(80)90120-6
  7. Lee, K.-H., K.-D. Jun, W.-S. Kim, and H.-D. Paik. 2001. Partial characterization of polyfermenticin SCD, a newly identified bacteriocin of Bacillus polyfermenticus. Lett. Appl. Microbiol. 32: 146-151
  8. Marshall, B. J. and S. R. Langton. 1986. Urea hydrolysis in patients with Campylobacter pyloridis infection. Lancet 1: 965-966
  9. Marshall, B. J., C. S. Goodwin, J. R. Warren, R. Murray, E. D. Blincow, S. J. Blackbourn, M. Phillips, T. E. Waters, and C. R. Sanderson. 1998. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 2: 1437-1442
  10. McNulty, C. A. M., M. P. Wilson, W. Havinga, B. Johnston, E. A. O’Gara, and D. J. Maslin. 2001. A pilot study to determine the effectiveness of garlic oil capsules in the treatment of dyspeptic patients with Helicobacter pylori. Helicobacter 6: 249-253
  11. Nam, G.-J., S.-W. Yeon, N.-S. Paek, T.-H. Kim, Y. H. Kim, C. J. Kim, and K. W. Kim. 1998. Isolation and structural determination of anti-Helicobacter pylori compound from Fungus 60686. Kor. J. Appl. Microbiol. Biotechnol. 26: 137-142
  12. O’Sullivan, G. C. 2001. Probiotics. Br. J. Surgery 88: 161- 162
  13. Peterson, W. L. 1991. Helicobacter pylori and peptic ulcer disease. N. Engl. J. Med. 324: 1043-1048 https://doi.org/10.1056/NEJM199104113241507
  14. Paik, H.-D. and B. A. Glatz. 1995. Purification and partial amino acid sequences of propionicin PLG-1, a bacteriocin produced by Propionibacterium thoenii P127. Lait 75: 367- 377
  15. Paik, H.-D., S.-S. Bae, S.-H. Park, and J.-G. Pan. 1997. Identification and partial characterization of tochicin, a bacteriocin produced by Bacillus thuringiensis subsp. tochigiensis. J. Ind. Microbiol. Biotechnol. 19: 294-298
  16. Paik, H.-D., N.-K. Lee, K.-H. Lee, Y.-I. Hwang, and J.-G. Pan. 2000. Identification and partial characterization of cerein BS229, a bacteriocin produced by Bacillus cereus BS229. J. Microbiol. Biotechnol. 10: 195-200
  17. Park, H.-S., S.-H. Lee, and T.-B. Uhm. 1998. Selection of microorganism for probiotics and their characterization. J. Kor. Soc. Food Sci. Nutr. 27: 433-440
  18. Park, K.-Y., H.-Y. Jung, K.-L. Woo, K.-D. Jun, J.-S. Kang, and H.-D. Paik. 2002. Effects of Bacillus polyfermenticus SCD administration on fecal microflora and putrefactive metabolites in healthy adults. J. Microbiol. Biotechnol. 12: 657-663
  19. Yee, Y.-K., M. W.-L. Koo, and M.-L. Szeto. 2002. Chinese tea consumption and low risk of Helicobacter infection. J. Gastro. Hepatol. 17: 552-555
  20. Young, K. A., P. P. Allaker, and J. M. Hardie. 2001. Morphological analysis of Helicobacter pylori from gastric biopsies and dental plaque by scanning electron microscopy. Oral Microbiol. Immunol. 16: 178-181 https://doi.org/10.1034/j.1399-302x.2001.016003178.x